ABBV vs. HD: AbbVie vs. Home Depot Stock Comparison
How do AbbVie (ABBV) and Home Depot (HD) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
AbbVie (ABBV) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas Home Depot (HD) belongs to Consumer Discretionary (Consumer Discretionary Distribution & Retail) — their GICS classifications point to very different parts of the market.
| Profile Item | ABBV | HD |
|---|---|---|
| Name | AbbVie Inc. | The Home Depot, Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Consumer Discretionary |
| GICS Industry Group | Pharmaceuticals, Biotechnology & Life Sciences | Consumer Discretionary Distribution & Retail |
| GICS Industry | Biotechnology | Specialty Retail |
| GICS Sub-Industry | Biotechnology | Home Improvement Retail |
| Market Capitalization | 505.89 billion USD | 338.26 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | January 2, 2013 | September 22, 1981 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | ABBV | HD |
|---|---|---|
| Total Return (1Y) | 28.47% | 4.89% |
| Total Return (3Y, Annualized) | 31.74% | 5.91% |
| Total Return (5Y, Annualized) | 24.08% | -1.20% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | ABBV | HD |
|---|---|---|
| Volatility (1Y, Annualized) | 25.31% | 27.38% |
| Beta (5Y) | 0.22 | 0.86 |
| Max Drawdown (5Y) | -21.92% | -34.73% |
| Avg. Volume (3M) | 4.85M | 4.80M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | ABBV | HD |
|---|---|---|
| Sharpe Ratio (1Y) | 0.94 | 0.01 |
| Sortino Ratio (1Y) | 1.45 | 0.02 |
Profitability
ROE (TTM)
Capital efficiency shows on one side only: Home Depot (HD) earns 94.80% on shareholders’ equity, ranked against its industry; AbbVie (ABBV) has no ROE this period.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
--
- Max
- 109.18%
- Q3
- 8.19%
- Median
- -26.53%
- Q1
- -61.44%
- Min
- -151.05%
- ABBV
- --
HD
Consumer Discretionary Distribution & Retail industry group
94.80%
- HD
- 94.80%
- Max
- 61.40%
- Q3
- 30.30%
- Median
- 15.79%
- Q1
- 7.77%
- Min
- -8.40%
Net Margin (TTM)
AbbVie (ABBV) at 15.67% retains a top-quartile share of revenue as profit, ahead of Home Depot (HD) at 8.38%, which keeps about the industry-typical share.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
15.67%
- Max
- 18.98%
- ABBV
- 15.67%
- Q3
- 5.73%
- Median
- 0.00%
- Q1
- -3.30%
- Min
- -16.57%
HD
Consumer Discretionary Distribution & Retail industry group
8.38%
- Max
- 20.47%
- Q3
- 9.34%
- HD
- 8.38%
- Median
- 3.97%
- Q1
- 1.29%
- Min
- -9.41%
Operating Margin (TTM)
Both AbbVie (ABBV) at 36.64% and Home Depot (HD) at 12.35% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
36.64%
- Max
- 80.14%
- ABBV
- 36.64%
- Q3
- 14.17%
- Median
- 0.00%
- Q1
- -65.77%
- Min
- -156.86%
HD
Consumer Discretionary Distribution & Retail industry group
12.35%
- Max
- 23.22%
- HD
- 12.35%
- Q3
- 11.30%
- Median
- 6.16%
- Q1
- 2.55%
- Min
- -2.67%
Profitability Metrics
| Metric | ABBV | HD |
|---|---|---|
| ROE (TTM) | -- | 94.80% |
| ROA (TTM) | 10.74% | 12.22% |
| Net Margin (TTM) | 15.67% | 8.38% |
| Operating Margin (TTM) | 36.64% | 12.35% |
| Gross Margin (TTM) | 73.72% | 33.05% |
Growth
Revenue Growth
Both AbbVie (ABBV) at 8.57% and Home Depot (HD) at 3.24% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Both AbbVie (ABBV) at -0.84% and Home Depot (HD) at -4.56% land near their industries' usual EPS growth ranges, so bottom-line momentum looks broadly in line with peers on both sides.
Growth Metrics
| Metric | ABBV | HD |
|---|---|---|
| Revenue Growth (YoY) | 8.57% | 3.24% |
| Revenue Growth (3Y CAGR) | 1.75% | 1.52% |
| EPS Growth (YoY) | -0.84% | -4.56% |
| EPS Growth (3Y CAGR) | -29.03% | -5.18% |
Financial Strength
Current Ratio (MRQ)
Home Depot (HD) at 1.08 keeps current ratio within its industry’s typical mid-range, while AbbVie (ABBV) at 0.87 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for ABBV.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
0.87
- Max
- 23.95
- Q3
- 11.13
- Median
- 5.04
- Q1
- 2.43
- ABBV
- 0.87
- Min
- 0.13
HD
Consumer Discretionary Distribution & Retail industry group
1.08
- Max
- 2.69
- Q3
- 1.74
- Median
- 1.36
- HD
- 1.08
- Q1
- 1.08
- Min
- 0.63
Debt / Equity (MRQ)
Only one side’s leverage can be read here: Home Depot (HD) carries debt-to-equity ratio of 3.42 against its industry range, while AbbVie (ABBV) reports no figure this period.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
--
- Max
- 1.44
- Q3
- 0.67
- Median
- 0.15
- Q1
- 0.02
- Min
- 0.00
- ABBV
- --
HD
Consumer Discretionary Distribution & Retail industry group
3.42
- Max
- 3.93
- HD
- 3.42
- Q3
- 2.03
- Median
- 1.25
- Q1
- 0.71
- Min
- 0.01
Financial Strength Metrics
| Metric | ABBV | HD |
|---|---|---|
| Current Ratio (MRQ) | 0.87 | 1.08 |
| Debt / Equity (MRQ) | -- | 3.42 |
| Net Debt / EBITDA | 2.21 | 2.35 |
Dividends
Dividend Yield (TTM)
Home Depot (HD) at 0.69% pays an industry-typical yield; AbbVie (ABBV) at 2.44% is above its entire peer range — the higher number, but one that calls for a look at payout sustainability before treating it as an advantage.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
2.44%
- ABBV
- 2.44%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
HD
Consumer Discretionary Distribution & Retail industry group
0.69%
- Max
- 5.44%
- Q3
- 2.38%
- HD
- 0.69%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
AbbVie (ABBV) reports payout ratio above 100% at 117.35%, meaning dividends exceeded current-period earnings and sustainability needs extra context. Meanwhile Home Depot (HD) reports 64.80%, ranking against industry peers normally.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
117.35%
- ABBV
- 117.35%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
HD
Consumer Discretionary Distribution & Retail industry group
64.80%
- Max
- 73.08%
- HD
- 64.80%
- Q3
- 32.26%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | ABBV | HD |
|---|---|---|
| Dividend Yield (TTM) | 2.44% | 0.69% |
| Dividend Payout Ratio (TTM) | 117.35% | 64.80% |
Valuation
P/E Ratio (TTM)
Both AbbVie (ABBV) at 49.18 and Home Depot (HD) at 23.54 sit in the richer earnings-multiple quartile for P/E ratio, so investors are paying more for TTM earnings than they pay for typical peers.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
49.18
- Max
- 91.23
- ABBV
- 49.18
- Q3
- 44.74
- Median
- 26.53
- Q1
- 13.26
- Min
- 0.06
HD
Consumer Discretionary Distribution & Retail industry group
23.54
- Max
- 36.35
- HD
- 23.54
- Q3
- 22.25
- Median
- 17.98
- Q1
- 11.86
- Min
- 4.22
P/S Ratio (TTM)
AbbVie (ABBV) at 7.66 is priced about in line with its industry on P/S ratio, while Home Depot (HD) at 1.98 sits in the pricier quartile — HD costs more per dollar of sales.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
7.66
- Max
- 46.64
- Q3
- 20.90
- ABBV
- 7.66
- Median
- 6.79
- Q1
- 3.12
- Min
- 0.01
HD
Consumer Discretionary Distribution & Retail industry group
1.98
- Max
- 3.79
- HD
- 1.98
- Q3
- 1.72
- Median
- 0.65
- Q1
- 0.27
- Min
- 0.03
P/B Ratio (MRQ)
AbbVie (ABBV) reports a negative P/B ratio of -110.37, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile Home Depot (HD) reports 18.60, ranking against industry peers normally.
ABBV
Pharmaceuticals, Biotechnology & Life Sciences industry group
-110.37
- Max
- 11.93
- Q3
- 6.36
- Median
- 3.19
- Q1
- 1.69
- Min
- -5.31
- ABBV
- -110.37
HD
Consumer Discretionary Distribution & Retail industry group
18.60
- HD
- 18.60
- Max
- 11.12
- Q3
- 5.25
- Median
- 2.06
- Q1
- 1.08
- Min
- -4.63
Valuation Metrics
| Metric | ABBV | HD |
|---|---|---|
| P/E Ratio (TTM) | 49.18 | 23.54 |
| P/S Ratio (TTM) | 7.66 | 1.98 |
| P/B Ratio (MRQ) | -110.37 | 18.60 |
| Free Cash Flow Yield (TTM) | 3.50% | 3.56% |